Literature DB >> 10911620

A yeast genetic assay for caspase cleavage of the amyloid-beta precursor protein.

P L Gunyuzlu1, W H White, G L Davis, G F Hollis, J H Toyn.   

Abstract

A functional assay for proteolytic processing of the amyloid precursor protein (APP) was set up in yeast. This consisted of a membrane-bound chimeric protein containing the beta-secretase cleaved C-terminal fragment of APP fused to the Ga14 transcription factor. Using this chimera in a GAL-reporter yeast strain, an expression library of human cDNAs was screened for clones that could activate the GAL-reporter genes by proteolytic processing of the membrane-bound APP-Gal4. Two human proteases, caspase-3 and caspase-8, were identified and confirmed to act by a mechanism that involved proteolysis at the site in the APP-Gal4 chimera that corresponded to the natural caspase cleavage site in APP, thus linking a readily scorable phenotype to proteolytic processing of APP. The activation of caspase-3 involved a mechanism that was independent of aspartic acid residue 175 at the cleavage site normally required for processing of caspase-3.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10911620     DOI: 10.1385/MB:15:1:29

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  40 in total

1.  Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.

Authors:  R Yan; M J Bienkowski; M E Shuck; H Miao; M C Tory; A M Pauley; J R Brashier; N C Stratman; W R Mathews; A E Buhl; D B Carter; A G Tomasselli; L A Parodi; R L Heinrikson; M E Gurney
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  Purification and cloning of amyloid precursor protein beta-secretase from human brain.

Authors:  S Sinha; J P Anderson; R Barbour; G S Basi; R Caccavello; D Davis; M Doan; H F Dovey; N Frigon; J Hong; K Jacobson-Croak; N Jewett; P Keim; J Knops; I Lieberburg; M Power; H Tan; G Tatsuno; J Tung; D Schenk; P Seubert; S M Suomensaari; S Wang; D Walker; J Zhao; L McConlogue; V John
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

3.  Processing of the amyloid protein precursor to potentially amyloidogenic derivatives.

Authors:  T E Golde; S Estus; L H Younkin; D J Selkoe; S G Younkin
Journal:  Science       Date:  1992-02-07       Impact factor: 47.728

Review 4.  Caspases: enemies within.

Authors:  N A Thornberry; Y Lazebnik
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 5.  Death by a thousand cuts: an ever increasing list of caspase substrates.

Authors:  C Stroh; K Schulze-Osthoff
Journal:  Cell Death Differ       Date:  1998-12       Impact factor: 15.828

Review 6.  Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide.

Authors:  C Haass; D J Selkoe
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

7.  Characterization of beta-amyloid peptide precursor processing by the yeast Yap3 and Mkc7 proteases.

Authors:  W Zhang; D Espinoza; V Hines; M Innis; P Mehta; D L Miller
Journal:  Biochim Biophys Acta       Date:  1997-11-27

8.  Substrate specificities of caspase family proteases.

Authors:  R V Talanian; C Quinlan; S Trautz; M C Hackett; J A Mankovich; D Banach; T Ghayur; K D Brady; W W Wong
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

9.  Yeast KEX2 genes encodes an endopeptidase homologous to subtilisin-like serine proteases.

Authors:  K Mizuno; T Nakamura; T Ohshima; S Tanaka; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1988-10-14       Impact factor: 3.575

10.  Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein.

Authors:  G L Caporaso; S E Gandy; J D Buxbaum; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

View more
  4 in total

Review 1.  Use of yeast as a model system to investigate protein conformational diseases.

Authors:  Christina M Coughlan; Jeffrey L Brodsky
Journal:  Mol Biotechnol       Date:  2005-06       Impact factor: 2.695

Review 2.  γ-Secretase inhibitors and modulators.

Authors:  Todd E Golde; Edward H Koo; Kevin M Felsenstein; Barbara A Osborne; Lucio Miele
Journal:  Biochim Biophys Acta       Date:  2013-06-17

3.  Type 3 Diabetes: Cross Talk between Differentially Regulated Proteins of Type 2 Diabetes Mellitus and Alzheimer's Disease.

Authors:  Khyati Mittal; Ruchi Jakhmola Mani; Deepshikha Pande Katare
Journal:  Sci Rep       Date:  2016-05-06       Impact factor: 4.379

Review 4.  Contribution of yeast models to neurodegeneration research.

Authors:  Clara Pereira; Cláudia Bessa; Joana Soares; Mariana Leão; Lucília Saraiva
Journal:  J Biomed Biotechnol       Date:  2012-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.